Hematology

Filter

chemotherapy

ASAP Trial Finds No Benefit for Pre-Transplant Chemotherapy in AML

November 2025

The ASAP trial shows immediate transplantation matches chemotherapy outcomes in AML, with genetics driving survival differences.

EHA – 2017 – Congress Highlights

Grab our full congress review of EHA 2017 in EMJ’s Hematology 5.1 eJournal. In the meantime take a look at this year’s congress highlights.

EMJ

EHA 2017 – Opening Ceremony

Our full congress review of EHA 2017 is now available for free in our Hematology 5.1 eJournal, and here is a look at the opening ceremony.

Spasmodic Dysphonia: What About It?

Spasmodic dysphonia (SD): what about it? That is the million-dollar question.

Improving Treatment Strategies for Patients with Follicular Lymphoma: How to Translate Novel Study Data into Clinical Practice

Ms Rosmarie Pfau detailed the challenges faced by patients with FL around the world, particularly a desire for improved quality of life (QoL) and…

The Simm Study: Survey of Integrative Medicine in Myeloproliferative Neoplasms

In patients with myeloproliferative neoplasms (MPN), including essential thrombocytosis (ET), polycythaemia vera (PV), and myelofibrosis (MF), symptoms…

Review of the 22nd European Hematology Association Congress 2017

The magnificent city of Madrid, Spain, welcomed this year’s annual European Association of Hematology (EHA) meeting, held from 22nd–25th June 2017.

Targeting Nanoparticles to Chronic Lymphocytic Leukaemia: Exploiting the Properties of CXCR4

A key aim of modern cancer medicine is the improvement of treatment efficacy and overall patient health using targeted therapies.

Shifting Treatment Paradigms in Non-Hodgkin Lymphomas

Despite significant therapeutic advances in the treatment of patients with non-Hodgkin lymphoma (NHL), a significant proportion experience relapse or…

Loading posts...

« Previous 1 … 77 78 79 80 81 … 95 Next »